Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of California, San Francisco
SWOG Cancer Research Network
Northwestern University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center